Skip to main content
. Author manuscript; available in PMC: 2009 Dec 1.
Published in final edited form as: J Affect Disord. 2009 Feb 24;118(1-3):19–27. doi: 10.1016/j.jad.2009.01.021

Table 1.

Demographic and clinical variables, information on Spectrum Measures and relevant statistics (mean, standard deviation, minimum-maximum scores)

Bipolar individuals Healthy individuals Statistics
N 14 16 n/a
Handedness Right Right n/a
Gender (female; male) 8; 6 8; 8 X2 = 0.14; p = 0.73
Age in years (Mean±SD; range) 32.64 ± 9.92; 23–52 28.50 ± 9.28; 18–52 t = −1.18; p = 0.24
NART (Mean ± SD; range) 111.77 ± 8.85; 92–121.58 118.08 ± 5.39; 101.11–125.14 t = 2.36*; p = 0.026
Illness duration in years (Mean ± SD; range) year 11.69 ± 6.32; 2–26 n/a n/a
Age-of-Illness onset (Mean ± SD; range) 22.00 ±8.99; 12–44 n/a n/a
HAM-D (version 25) (Mean ± SD; range) 3.0 ± 4.843; 0–18 n/a n/a
YMRS (Mean ± SD; range) 1.54 ± 2.60; 0–9 n/a n/a
Spectrum measures
Eating disorder 42.57 ± 35.22; 17.00 ± 15.63; t = −2.19;
(Mean ± SD; minimum-maximum) 1–96 6–52 p = 0.04
Substance use 34.71 ± 27.20; 18.27±15.78; t = −2.17;
(Mean ± SD; minimum-maximum) 8–97 0–54 p = 0.04
Medication - BD individuals only

Mood-stabilizers Antipsychotics Antidepressants Anxiolytics

Name of medication; number of bipolar individuals taking 1Lithium; n = 3 7Risperidone; n = 2 15Bupropion; n = 1 10Lorazepam; n = 3
6Valproate; n = 2 2Aripiprazole; n = 6 12Sertraline; n = 1 4Clonazepam; n = 1
5Lamotrigine; n = 1 11Quetiapine; n = 1 9Paroxetine; n = 1
14Carbamazepine; n = 1 3Olanzapine; n = 1 13Venlafaxine; n = 2
8Gabapentin; n = 1
Monotherapy N = 1 (1) N = 3 (2) N = 0 N = 0
Combination treatment

Mood-stabilizers and antipsychotic N = 1 (2 5 6)
Mood-stabilizers, antipsychotic, antidepressant and anxiolytic N = 1 (1 2 7 8 9 10)
Mood-stabilizers and antidepressant N = 2 (1 6 13)
Mood-stabilizers, antidepressant and anxiolytic N = 1 (1 2 7 8 9 10)
Antipsychotics and antidepressants N = 1 (11 12)
Antipsychotics and anxiolytics N = 2 (2 3 4 7 10)

Illness history information (illness duration; age-of-illness onset; HAM-D and YMRS scores) and medication information for bipolar individuals. Names/types of medication and the number of bipolar patients who took these combinations. Numbers in superscript denote types of medication taken in either mono-therapies or combination treatment.